Interview: AIPLA President Denise DeFranco

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Interview: AIPLA President Denise DeFranco

DeFranco_Denise_crop_100

Looking back on a whirlwind year: Denise DeFranco reflects on her term as AIPLA President, which included the passage of the Defend Trade Secrets Act and ramping up of the Association's publications



DeFranco-Denise

Denise DeFranco says her year as AIPLA President has been a whirlwind.

"The one thing that I have learned this year is exactly how much AIPLA does for its members and for the IP community as a whole," she says.

"I initially saw the leadership of AIPLA through the lens of the amicus work that the association does, that was my sweet spot and what I really had a passion for. As I have been involved in the leadership, I have learned all of the other things that we do for our members, everything from networking opportunities to education to advocacy in other forums, not just amicus briefs. The list just goes on and on. So in the past year I have really come to appreciate all that the Association has to offer its members and the IP community as a whole."

One goal DeFranco had for the year was to "bring some life to AIPLA's publication efforts." 

She started the Special Committee on Publications to give members a platform for publishing their works. "We have really put into place a process for generating an extensive library of books for our members to learn from but also opportunities for our members to publish," says DeFranco.

This year, in cooperation with Bloomberg BNA, AIPLA published a book titled "Patents After the AIA", and the Association is working on books on design patents, the new trade secrets law, and patents on standards. "We are putting together a good library on a broad range of topics," she says. "I am really pleased with how that is going."

The trade secrets book would be timely, with the Defend Trade Secrets Act (DTSA) signed into law in May.

"AIPLA played our part in helping to work with the Hill in getting something enacted," says DeFranco. "That's something we are really proud of. The DTSA creates a federal civil cause of action for trade secret misappropriation, which has long been needed in our IP jurisprudence. I think AIPLA can be proud of its contribution to help move that forward."

DeFranco says the DTSA is already having an effect.

"I wouldn't say it is necessarily manifesting itself in lawsuits at the moment," she says. "The way it is manifesting itself is that corporations are at this point more seriously considering trade secrets as a viable strong alternative to patent protection. It is becoming a more important part of the complement of IP that is available to corporations. It has always been there, but I think with this federal statute now available it really makes it much stronger."

The year also included a change of job for DeFranco. She left Finnegan to become global head of IP litigation at Johnson & Johnson.



more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article